Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;17(Suppl 1):S137-S140.
doi: 10.4103/jpbs.jpbs_1876_24. Epub 2025 Apr 21.

Evaluating the Effectiveness of Platelet Rich Plasma Therapy in Enhancing Endometrial Receptivity for Women with Infertility: A Narrative Review

Affiliations
Review

Evaluating the Effectiveness of Platelet Rich Plasma Therapy in Enhancing Endometrial Receptivity for Women with Infertility: A Narrative Review

Priya Chatterjee et al. J Pharm Bioallied Sci. 2025 May.

Abstract

Infertility is a condition that affects a significant percentage of couples globally, affecting their social and psychological well-being. It disrupts many aspects of life, influencing individuals' social and psychological experiences. The primary causes of infertility are diverse and include endogenous factors, various psychological variables, congenital or acquired disorders in females, and genetic and hormonal issues in males. In females, implantation failure is a key obstacle to successful embryo implantation, with poor endometrial receptivity being a major contributing factor. Several methods have been explored to enhance endometrial thickness and improve implantation success rates. These include treatments such as granulocyte-colony stimulating factor, low-dose acetylsalicylic acid, vaginal sildenafil, and estrogens. Among these, platelet-rich plasma (PRP) has emerged as a promising approach. PRP, derived from the patient's own blood, is rich in growth factors such as platelet-derived growth factor (PDGF), transforming growth factor (TGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF). These factors are crucial in promoting cell replication and tissue regeneration. PRP therapy has shown significant potential in enhancing endometrial proliferation and improving pregnancy rates, particularly in patients with thin endometrium and those with a history of recurrent implantation failure. Numerous studies have reported that intrauterine PRP treatment leads to increased endometrial thickness and better clinical pregnancy outcomes. The PRP is obtained through a centrifugation process that separates platelet-rich plasma from red blood cells. This PRP is then injected into the endometrial cavity, typically midcycle, to boost endometrial receptivity. Systematic reviews have consistently highlighted the positive effects of PRP treatment on pregnancy outcomes in women with thin endometrium, offering hope to those facing challenges with implantation and fertility. PRP therapy represents a promising advancement in reproductive medicine, providing an effective option for improving endometrial receptivity and achieving successful pregnancies.

Keywords: Endometrium thickness (ET); infertility; platelet-rich plasma (PRP); pregnancy.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Steps of formation of PRP

Similar articles

References

    1. Zargar M, Pourjafar Z, Salemi S, Barati M. Evaluation of the consequences of double ovarian stimulation through shanghai protocol in patients with poor ovarian respond. In Review. 2022. [[Last accessed on 2024 Feb 5]]. Feb. Available from: https://www.researchsquare.com/article/rs-1283105/v1 .
    1. Mahajan S, More A, Dutta S, Chaudhary N, Nawale N. The effect of superoxide dismutase mimetic drug in an infertile patient with thin endometrium. Cureus. 2024;16:e53077. - PMC - PubMed
    1. Dogra Y, Singh N, Vanamail P. Autologous platelet-rich plasma optimizes endometrial thickness and pregnancy outcomes in women with refractory thin endometrium of varied aetiology during fresh and frozen-thawed embryo transfer cycles. JBRA Assist Reprod. 2022;26:13–21. - PMC - PubMed
    1. Zadehmodarres S, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: A pilot study. JBRA Assist Reprod. 2017;21:54–6. - PMC - PubMed
    1. Anitua E, Allende M, de la Fuente M, Del Fabbro M, Alkhraisat MH. Efficacy of platelet-rich plasma in women with a history of embryo transfer failure: A systematic review and meta-analysis with trial sequential analysis. Bioeng Basel Switz. 2023;10:303. - PMC - PubMed

LinkOut - more resources